[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].Medicina (B Aires). 2020; 80 Suppl 3:65-66.M
Abstract
Although the incidence is uncertain, some case reports suggest that COVID 19 infection is associated with an increased risk of venous thromboembolism. We suggest starting prophylactic anticoagulant therapy for all patients hospitalized with a symptomatic infection with COVID-19, unless contraindicated, with enoxaparin 40 mg SC daily if creatinine clearance is greater than 30 ml/min.
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
spa
PubMed ID
32658849
Citation
Vazquez, Fernando J., et al. "[Recommendations for the Use of Thromboprophylaxis in Hospitalized Patients With COVID-19 in Argentina]." Medicina, vol. 80 Suppl 3, 2020, pp. 65-66.
Vazquez FJ, Korin J, Baldessari EM, et al. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]. Medicina (B Aires). 2020;80 Suppl 3:65-66.
Vazquez, F. J., Korin, J., Baldessari, E. M., Capparelli, F. J., Gutierrez, P., Pale, C., Bocanegra, F., Grand, B., Penchasky, D., Gonzalez Alcántara, M. M., Prémoli, M. S., Tabares, A., Wainsztein, N., Odetto, D., Vaccaro, C., Martínez Aquino, E., Cumpian, O., Falabella, V., Antuel García, S., ... Gándara, E. (2020). [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina]. Medicina, 80 Suppl 3, 65-66.
Vazquez FJ, et al. [Recommendations for the Use of Thromboprophylaxis in Hospitalized Patients With COVID-19 in Argentina]. Medicina (B Aires). 2020;80 Suppl 3:65-66. PubMed PMID: 32658849.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
AU - Vazquez,Fernando J,
AU - Korin,Jorge,
AU - Baldessari,Enrique M,
AU - Capparelli,Federico J,
AU - Gutierrez,Paula,
AU - Pale,Carlos,
AU - Bocanegra,Florencia,
AU - Grand,Beatriz,
AU - Penchasky,Diana,
AU - Gonzalez Alcántara,María Mónica,
AU - Prémoli,María Sol,
AU - Tabares,Aldo,
AU - Wainsztein,Néstor,
AU - Odetto,Diego,
AU - Vaccaro,Carlos,
AU - Martínez Aquino,Eleno,
AU - Cumpian,Olga,
AU - Falabella,Verónica,
AU - Antuel García,Santiago,
AU - Saadi,José,
AU - Siccardi,Mariana,
AU - Gándara,Esteban,
PY - 2020/7/14/entrez
PY - 2020/7/14/pubmed
PY - 2020/8/8/medline
KW - COVID-19
KW - anticoagulant drugs
KW - heparin
KW - prophylaxis
KW - pulmonary embolism
KW - venous thrombosis
SP - 65
EP - 66
JF - Medicina
JO - Medicina (B Aires)
VL - 80 Suppl 3
N2 - Although the incidence is uncertain, some case reports suggest that COVID 19 infection is associated with an increased risk of venous thromboembolism. We suggest starting prophylactic anticoagulant therapy for all patients hospitalized with a symptomatic infection with COVID-19, unless contraindicated, with enoxaparin 40 mg SC daily if creatinine clearance is greater than 30 ml/min.
SN - 1669-9106
UR - https://www.unboundmedicine.com/medline/citation/32658849/[Recommendations_for_the_use_of_thromboprophylaxis_in_hospitalized_patients_with_COVID_19_in_Argentina]_
DB - PRIME
DP - Unbound Medicine
ER -
